General practitioner assessment of stage and performance status in lung cancer patients at a population level: Implications for prognosis and radiotherapy needs analyses

Lung Cancer

Volumn 57, Issue 3, 2007, Pages 381-388

  Tyldesley, S ^a   Roques, T W ^b   Erridge, S ^c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

General practitioner; Lung cancer; Needs analysis; Performance status; Population based; Referral; Stage

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANADA; CANCER CENTER; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; GENERAL PRACTITIONER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; WEIGHT REDUCTION;

BRITISH COLUMBIA; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PHYSICIANS, FAMILY; POPULATION; PROGNOSIS; QUESTIONNAIRES;

EID: 34548015887     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.03.024     Document Type: Article

References (22)

1. Adebonojo S.A., Bowser A.N., Moritz D.M., and Corcoran P.C. Impact of revised stage classification of lung cancer on survival: a military experience. Chest 115 6 (1999) 1507-1513
2. van Rens M.T., de la Riviere A.B., Elbers H.R., and van Den Bosch J.M. Prognostic assessment of 2361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 117 2 (2000) 374-379
3. Hoang T., Xu R., Schiller J.H., Bonomi P., and Johnson D.H. Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data. J Clin Oncol 23 1 (2005) 175-183
4. Pater J.L., and Loeb M. Nonanatomic prognostic factors in carcinoma of the lung: a multivariate analysis. Cancer 50 2 (1982) 326-331
5. Stanley K.E. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 65 1 (1980) 25-32
6. Fry W.A., Menck H.R., and Winchester D.P. The National Cancer Data Base Report on Lung Cancer. Cancer 77 9 (1996) 1947-1955
7. British Columbia Cancer Agency Cancer Management Guidelines for Lung Cancer. Accessed on line Jan 2007. http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Lung/6ManagementPolicies/641NonSmallCellLungCancer/07CurativeIntentTherapyforUnresectableStageIIINSCLC.htm.
8. National Cancer Institute-Physician Data Query. Lung Cancer Treatment. http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell lung /HealthProfessional/page10. Accessed on line Jan 2007.
9. Erridge S., Thomson C., Davidson J., Jones R.D., and Price A. Factors influencing the use of thoracic radiotherapy in lung cancer-an analysis of the 1995 Scottish Lung Cancer Audit. Clin Oncol 14 (2002) 219-227
10. Laskin J., Erridge S., Coldman A., D'Yachkova Y., Speers C., Westeel V., et al. Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia. Lung Cancer 43 (2004) 7-16
11. Richardson G.E., Thursfield V.J., and Giles G.G. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group. Med J Aust 172 (2000) 321-324
12. Gregor A., Thomson C.S., Brewster D.H., Stroner P.L., Davidson J., Fergusson R.J., et al. Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax 56 (2001) 212-217
13. Janssen-Heijnen M.L.G., Schipper R.M., Razenberg P.P.A., Crommelin M.A., and Coebergh J.W. Prevalence of co-morbidity in lung cancer patients and it relationship with treatment: a population-based study. Lung Cancer 21 (1998) 105-113
14. Delaney G., Barton M., Jacob S., and Jalaludin B. A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol 4 2 (2003) 120-128
15. Tyldesley S., Boyd C., Schulze K., Walker H., and Mackillop W.J. Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Rad Onc Biol Phys 49 (2001) 973-985
16. Radiotherapy Activity Planning Group. Radiotherapy activity planning for Scotland 2011-2015. http://www.scotland.gov.uk/Publications/2006/01/24131719/28. Accessed on line Jan 2007.
17. Collaboration for Cancer Outcomes Research and Evaluation. Radiotherapy in Cancer Care: estimating the optimal utilization from a review of evidence-based clinical guidelines. http://www.ncci.org.au/projects/radiotherapy/radio_compare.htm. Accessed on line Jan 2007.
18. Bentzen S.M., Heeren G., Cottier B., Slotman B., Glimelius B., Lievens Y., et al. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiother Oncol 75 (2005) 355-365
19. Brown J.S., Eraut D., Trask C., and Davison A.G. Age and the treatment of lung cancer. Thorax 51 (1996) 564-568
20. de Rijke J.M., Schouten L.J., ten Velde G.P.M., Wanders S.L., Bollen E.C., Lalisang R.I., et al. Influence of age, comorbidity and PS on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study. Lung Cancer 46 (2004) 233-245
21. Roila F., Lupattelli M., Sassi M., Basurto C., Bracarda S., Picciafuoco M., et al. Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales. Ann Oncol 2 6 (1991) 437-439
22. Conill C., Verger E., and Salamero M. Performance status assessment in cancer patients. Cancer 65 8 (1990) 1864-1866